Clopivas AP 150 Tablet
By Clopivas AP
Rx
15 Tablet in a Strip

Composition
Aspirin(150mg) + Clopidogrel(75mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
June, 2026

liver
When using Clopivas AP 150 Tablet, it is important to exercise caution if you have liver disease. Your doctor may need to adjust the dosage accordingly. It is not advised to use Clopivas AP 150 Tablet in cases of severe liver disease. If you have a history of liver conditions, consult your doctor before taking Clopivas AP 150 Tablet to ensure proper guidance and dosage adjustments.

kidney
When using Clopivas AP 150 Tablet, caution is advised for patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Avoid in cases of severe kidney disease. Follow medical advice closely.

alcohol
It is advisable to avoid drinking alcohol while taking Clopivas AP 150 Tablet. Combining alcohol with this medication can increase the risk of stomach ulcer and gastric bleeding.

driving
Clopivas AP 150 Tablet may decrease alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms. Clopivas AP 150 Tablet does not impact driving ability.

pregnancy
Clopivas AP 150 Tablet is unsafe during pregnancy, as it poses a risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Clopivas AP 150 Tablet should be used with caution during breastfeeding as it may pass into breastmilk and potentially harm the baby. It is advisable to consult a healthcare provider before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹104.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024